TB-500 Side Effects: What the Research Says
TB-500 is a synthetic fragment of thymosin beta-4 studied for repair and cell migration. Questions about its tolerability are common. This overview summarizes reported effects from research and community sources. It is research information, not medical advice.
General tolerability
In animal research TB-500 has shown a wide margin without frequent serious adverse effects. Human clinical evidence is limited, so its safety profile in people is not formally established. That gap is the core reason it remains a research compound.
Reported effects
- Injection site reactions: temporary redness or irritation.
- Fatigue: some reports describe tiredness in the hours after a dose, often during the loading phase.
- Head rush or lightheadedness: occasionally noted.
- Flu-like feeling: a small number of reports mention this early in a protocol.
Quality and contaminants
As with any research peptide, a portion of reported effects likely comes from impure material rather than the compound. Third-party tested sources reduce this variable. Compare vendors on the supplier list, and follow method notes on the TB-500 protocol page.
What remains unknown
Long term human safety, drug interactions, and effects in specific populations are not established. There is also discussion in sports contexts because TB-500 appears on some prohibited substance lists, which is a compliance point for researchers to be aware of.